Caroline Hurault-Delarue

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Neuropathic Pain

Top Venues

Pharmacoepidemiology and drug safety

Fundamental & clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Justine Benevent, Mélanie Araujo, Anna-Belle Beau, Diane Sicard, Agnes Sommet, Caroline Hurault-Delarue, Isabelle Lacroix, Christine Damase-Michel
First trimester pregnancy exposure to fosfomycin and risk of major congenital anomaly: a comparative study in the EFEMERIS database. Infection (2022)
Mélanie Araujo, Caroline Hurault-Delarue, Agnes Sommet, Christine Damase-Michel, Isabelle Lacroix
Topical sertaconazole during pregnancy and risk of adverse pregnancy outcome and major congenital anomalies: Comparative study in the EFEMERIS database. Mycoses 65 (4) (2022)
Caroline Hurault-Delarue, Mélanie Araujo, Clémentine Vabre, Justine Benevent, Christine Damase-Michel, Isabelle Lacroix
What changes in prescription patterns of antiemetic medications in pregnant women in France? Fundamental & clinical pharmacology 35 (6) (2021)
Rachel Charlton, Christine Damase-Michel, Caroline Hurault-Delarue, Rosa Gini, Maria Loane, Anna Pierini, Aurora Puccini, Amanda Neville, Julia Snowball, Joan K Morris, null null
Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016. Pharmacoepidemiology and drug safety 28 (11) (2019)
Caroline Hurault-Delarue, Joan K Morris, Rachel Charlton, Rosa Gini, Maria Loane, Anna Pierini, Aurora Puccini, Amanda Neville, Julia Snowball, Christine Damase-Michel, null null
Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries. Pharmacoepidemiology and drug safety 28 (11) (2019)
Caroline Hurault-Delarue, Cécile Chouquet, Nicolas Savy, Isabelle Lacroix, Anna-Belle Beau, Jean-Louis Montastruc, Christine Damase-Michel
Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics. Pharmacoepidemiology and drug safety 26 (5) (2017)